Found "Medical Devices": 251 results
Cross-Country Conversations: Health Technology Assessment (HTA) Experiences from India and Thailand
India has established Health Technology Assessment (HTA) to increase the use of evidence in informing health policy decisions. The Post-Graduate Institute of Medical Education and Research (PGIMER), a resource hub for HTA and a leading public health institution in India, hosted a workshop titled “Co
Implementing Health Tech for UHC: Real-World Lessons from PMAC 2025
The rapid advancement of technology is reshaping global health, offering new opportunities to strengthen health systems. The Prince Mahidol Award Conference (PMAC) 2025, under the theme of “Harnessing Technologies in an Age of AI to Build a Healthier World,” provided invaluable insights into the com
Is AI the Answer? Exploring the Challenges and Solutions of AI in Strengthening Health Systems: Insights from PMAC 2025
At the recent Prince Mahidol Award Conference (PMAC) 2025, the Health Intervention and Technology Assessment Program (HITAP) Foundation hosted a side meeting on the role of artificial intelligence (AI) in healthcare. This meeting “Is AI a Panacea for the Health Sector? Navigating the Barriers to Ado
Strengthening Health Technology Assessment in Asia: Insights from the 3rd Regional Workshop on Advanced Economic Evaluation Modeling
Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki
After Delay, OxyContin’s Use in Young Is Under Study
To learn how best to prescribe powerful drugs to children, Congress passed a law in the 1990s that rewarded drug makers for conducting clinical studies involving children. Among the incentives for cooperating companies was a possible six-month extension of protection from generic competition after a
F.D.A. Expedites Review of New Uses for Anticlotting Drug
The Food and Drug Administration has agreed to give priority status to its review of three new uses for the anticlotting drug Xarelto, Johnson & Johnson announced Monday.The company is asking the agency to approve the drug to treat deep vein thrombosis and pulmonary embolism, and to prevent recu
Glaxo Agrees to Pay $3 Billion in Fraud Settlement
In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, f
EU agency lifts lid on drug data secrets
(Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E
Vast F.D.A. Effort Tracked E-Mails of Its Scientists
WASHINGTON — A wide-ranging surveillance operation by the Food and Drug Administration against a group of its own scientists used an enemies list of sorts as it secretly captured thousands of e-mails that the disgruntled scientists sent privately to members of Congress, lawyers, labor officials, jou
Rational use of Health Technology: A collaborative program between the Consortium of Thai Medical Schools and Health Intervention and Technology Assessment Program
This short training aims to equip administrator and medical instructors with skill in the selection of appropriate health technologies, and to give guidance in doing a relevant research that benefit the country. 201-203-2553Capacity building,Consortium of Thai Medical Schools,ความร่วมมือ
10 / Page